U.S Botox Promotional Activity Report 2016-2017 – Research and Markets

DUBLIN–(BUSINESS WIRE)–The "Botox
2016 U.S Promotional Report" report has been added to Research
and Markets' offering.

The 5 Key Questions Addressed by this Report:

• How many physicians were reached by Botox through personal promotion
  in 2016 and how does this compare to its peer set in the
  Blepharospasm, Facial Wrinkles, Glabellar Lines, Hyperhidrosis,
  Migraine, Muscle Spasticity, Overactive Bladder, Strabismus, and
  Torticollis markets?
• What promotional mix was leveraged (e.g., sales rep detailing,
  physician education, and paid speaking) and what was the median spend
  on each type of activity?
• How does Allergan's depth of coverage vary within key specialties
  (e.g., Neurology, Ophthalmology, Urology, Optometry, Dermatology,
  Plastic Surgery, and Physical Medicine and Rehabilitation) and how
  does this compare to its peers and the overall set of rep-accessible
  physicians?
• How often are physicians receiving paid meals for Botox throughout the
  year (e.g., monthly, quarterly, annually)?
• Who were the most detailed prescribers and top paid speakers for Botox
  in 2016?

Data Sources and Methodology:

• We leverage company-reported financial transaction data disclosed
  through CMS Open Payments. This data set captures all transfers of
  value (e.g., speaking fees, consulting fees, travel, education, and
  meals) made on behalf of a drug or device manufacturer to a physician.
  Currently, 42 months of longitudinal data is available – covering
  payments to more than 900,000 U.S. healthcare professionals.
• Over 31,000 paid interactions across 14,700 physicians made on behalf
  of Botox were carefully examined to support our analysis. In addition,
  interaction data from 18 peer products (e.g. Amrix, Bupap, Cambia,
  Dysport, Gablofen, Lorzone, Myobloc, Myrbetriq, Onzetra Xsail, Relpax,
  Sumavel Dosepro, Toviaz, Treximet, VESIcare, Xeomin, Zecuity,
  Zembrace, and Zomig ) was leveraged to provide benchmarking and market
  insights.

For more information about this report visit https://www.researchandmarkets.com/research/klphcs/u_s_botox?w=4

Contacts

Research and Markets
Laura Wood, Senior Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Central
Nervous System Drugs